Physician profile
Max Ruge
NPI 1568081552
$2,767.75
in general payments reported to CMS, 2019-2025
9 companies · $1,617 in 2025
The $1,617 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $52.04 · 2024: $1,098 · 2025: $1,617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,115 · Education: $356 · Travel and Lodging: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,115.16 |
| Education | $355.85 |
| Travel and Lodging | $296.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $897.93 | 2025 | Farapulse, Electrophysiology Cable, Accolade Sr |
| Atricure, INC. | $893.39 | 2024 | |
| Biotronik INC. | $426.60 | 2025 | |
| Medtronic, INC. | $291.29 | 2023-2025 | Azure Xt Dr Mri Surescan, Mycarelink, Linq II |
| Abiomed | $101.30 | 2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $88.33 | 2024 | |
| Amgen INC. | $31.36 | 2023-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $21.01 | 2025 | |
| Philips North America LLC | $16.54 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Max Ruge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.